STOCK TITAN

[144] Disc Medicine, Inc. SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
144
Rhea-AI Filing Summary

Disc Medicine, Inc. (IRON) filed a Form 144 reporting a proposed sale of 12,862 shares of common stock through Merrill Lynch One Bryant Park (New York) with an aggregate market value of $785,868.20. The filing states the company has 34,765,581 shares outstanding and lists the approximate sale date as 08/14/2025 on the Nasdaq.

The securities were originally acquired on 05/01/2020 in a private placement from the issuer, paid in cash. The filer reports no securities sold in the past three months and includes the standard representation that the seller does not possess undisclosed material adverse information. The notice includes the usual signature and legal attestation language.

Disc Medicine, Inc. (IRON) ha presentato un Form 144 comunicando la proposta di vendita di 12.862 azioni ordinarie tramite Merrill Lynch One Bryant Park (New York) per un valore di mercato complessivo di $785.868,20. Il documento indica che la società ha in circolazione 34.765.581 azioni e riporta la data approssimativa di vendita come 14/08/2025 sul Nasdaq.

I titoli sono stati originariamente acquisiti il 01/05/2020 tramite una private placement emessa dall’azienda e pagati in contanti. Il dichiarante segnala di non aver venduto titoli nei tre mesi precedenti e include la consueta dichiarazione che il venditore non è in possesso di informazioni riservate di natura negativa. L’avviso contiene le firme e le attestazioni legali abituali.

Disc Medicine, Inc. (IRON) presentó un Form 144 informando de una propuesta de venta de 12.862 acciones ordinarias a través de Merrill Lynch One Bryant Park (Nueva York) por un valor de mercado agregado de $785.868,20. El formulario indica que la compañía tiene 34.765.581 acciones en circulación y apunta la fecha aproximada de la venta como 14/08/2025 en Nasdaq.

Los valores fueron adquiridos originalmente el 01/05/2020 en una private placement del emisor, pagados en efectivo. El declarante informa que no vendió valores en los últimos tres meses e incluye la representación estándar de que el vendedor no posee información adversa material no divulgada. El aviso incorpora las firmas y las certificaciones legales habituales.

Disc Medicine, Inc. (IRON)12,862주의 보통주를 Merrill Lynch One Bryant Park(뉴욕)를 통해 매도할 예정임을 신고하는 Form 144를 제출했으며, 총 시가 가치는 $785,868.20로 보고되었습니다. 제출서에 따르면 회사의 발행 주식 수는 34,765,581주이며, 매도 예정일은 나스닥에서 2025/08/14로 표기되어 있습니다.

해당 증권은 원래 2020/05/01에 발행사로부터의 프라이빗 플레이스먼트(private placement)로 현금 지급을 통해 취득된 것입니다. 제출인은 최근 3개월간 증권을 매각한 사실이 없음을 보고하고 있으며, 판매자가 공개되지 않은 중대한 불리한 정보를 보유하고 있지 않다는 통상적인 진술을 포함하고 있습니다. 통지서에는 일반적인 서명 및 법적 확인 문구가 포함되어 있습니다.

Disc Medicine, Inc. (IRON) a déposé un Form 144 signalant la proposition de vente de 12 862 actions ordinaires via Merrill Lynch One Bryant Park (New York) pour une valeur de marché totale de $785 868,20. Le document indique que la société a 34 765 581 actions en circulation et mentionne la date approximative de vente comme le 14/08/2025 sur le Nasdaq.

Les titres ont été acquis à l’origine le 01/05/2020 dans le cadre d’un private placement auprès de l’émetteur, payés en espèces. Le déclarant signale n’avoir vendu aucun titre au cours des trois derniers mois et inclut la déclaration standard selon laquelle le vendeur ne détient pas d’informations défavorables importantes non divulguées. L’avis comprend les signatures et les attestations juridiques habituelles.

Disc Medicine, Inc. (IRON) reichte ein Form 144 ein und meldete den geplanten Verkauf von 12.862 Stammaktien über Merrill Lynch One Bryant Park (New York) mit einem Gesamtmarktwert von $785.868,20. Die Einreichung gibt an, dass das Unternehmen 34.765.581 ausgegebene Aktien hat und nennt das ungefähre Verkaufsdatum als 14.08.2025 an der Nasdaq.

Die Wertpapiere wurden ursprünglich am 01.05.2020 in einer Private Placement vom Emittenten erworben und bar bezahlt. Der Meldende berichtet, in den letzten drei Monaten keine Wertpapiere veräußert zu haben, und enthält die übliche Erklärung, dass der Verkäufer keine nicht offengelegten, wesentlichen nachteiligen Informationen besitzt. Die Mitteilung enthält die üblichen Unterschriften- und Rechtsbeglaubigungsformeln.

Positive
  • None.
Negative
  • None.

Insights

TL;DR: Small insider/affiliate sale disclosed; size is immaterial relative to outstanding shares and unlikely to move the market.

The proposed sale of 12,862 shares equals roughly 0.037% of the reported 34,765,581 shares outstanding, indicating a modest disposition. The shares were acquired in a private placement on 05/01/2020 and are being sold through a major broker, which suggests a routine liquidity transaction rather than a strategic change. No prior three-month sales are reported, reducing concerns about staged divestment. From a market-impact perspective this notice is neutral.

TL;DR: Filing meets Rule 144 disclosure requirements and contains the standard seller attestation; no governance red flags visible.

The Form 144 provides required details: acquisition date, nature of acquisition (private placement from the issuer), payment method (cash), broker name, proposed sale date, and aggregate value. The attestation that the seller lacks undisclosed material adverse information is included. With no evidence of concurrent unusual activity or repeated recent sales, this filing appears compliant and routine from a governance standpoint.

Disc Medicine, Inc. (IRON) ha presentato un Form 144 comunicando la proposta di vendita di 12.862 azioni ordinarie tramite Merrill Lynch One Bryant Park (New York) per un valore di mercato complessivo di $785.868,20. Il documento indica che la società ha in circolazione 34.765.581 azioni e riporta la data approssimativa di vendita come 14/08/2025 sul Nasdaq.

I titoli sono stati originariamente acquisiti il 01/05/2020 tramite una private placement emessa dall’azienda e pagati in contanti. Il dichiarante segnala di non aver venduto titoli nei tre mesi precedenti e include la consueta dichiarazione che il venditore non è in possesso di informazioni riservate di natura negativa. L’avviso contiene le firme e le attestazioni legali abituali.

Disc Medicine, Inc. (IRON) presentó un Form 144 informando de una propuesta de venta de 12.862 acciones ordinarias a través de Merrill Lynch One Bryant Park (Nueva York) por un valor de mercado agregado de $785.868,20. El formulario indica que la compañía tiene 34.765.581 acciones en circulación y apunta la fecha aproximada de la venta como 14/08/2025 en Nasdaq.

Los valores fueron adquiridos originalmente el 01/05/2020 en una private placement del emisor, pagados en efectivo. El declarante informa que no vendió valores en los últimos tres meses e incluye la representación estándar de que el vendedor no posee información adversa material no divulgada. El aviso incorpora las firmas y las certificaciones legales habituales.

Disc Medicine, Inc. (IRON)12,862주의 보통주를 Merrill Lynch One Bryant Park(뉴욕)를 통해 매도할 예정임을 신고하는 Form 144를 제출했으며, 총 시가 가치는 $785,868.20로 보고되었습니다. 제출서에 따르면 회사의 발행 주식 수는 34,765,581주이며, 매도 예정일은 나스닥에서 2025/08/14로 표기되어 있습니다.

해당 증권은 원래 2020/05/01에 발행사로부터의 프라이빗 플레이스먼트(private placement)로 현금 지급을 통해 취득된 것입니다. 제출인은 최근 3개월간 증권을 매각한 사실이 없음을 보고하고 있으며, 판매자가 공개되지 않은 중대한 불리한 정보를 보유하고 있지 않다는 통상적인 진술을 포함하고 있습니다. 통지서에는 일반적인 서명 및 법적 확인 문구가 포함되어 있습니다.

Disc Medicine, Inc. (IRON) a déposé un Form 144 signalant la proposition de vente de 12 862 actions ordinaires via Merrill Lynch One Bryant Park (New York) pour une valeur de marché totale de $785 868,20. Le document indique que la société a 34 765 581 actions en circulation et mentionne la date approximative de vente comme le 14/08/2025 sur le Nasdaq.

Les titres ont été acquis à l’origine le 01/05/2020 dans le cadre d’un private placement auprès de l’émetteur, payés en espèces. Le déclarant signale n’avoir vendu aucun titre au cours des trois derniers mois et inclut la déclaration standard selon laquelle le vendeur ne détient pas d’informations défavorables importantes non divulguées. L’avis comprend les signatures et les attestations juridiques habituelles.

Disc Medicine, Inc. (IRON) reichte ein Form 144 ein und meldete den geplanten Verkauf von 12.862 Stammaktien über Merrill Lynch One Bryant Park (New York) mit einem Gesamtmarktwert von $785.868,20. Die Einreichung gibt an, dass das Unternehmen 34.765.581 ausgegebene Aktien hat und nennt das ungefähre Verkaufsdatum als 14.08.2025 an der Nasdaq.

Die Wertpapiere wurden ursprünglich am 01.05.2020 in einer Private Placement vom Emittenten erworben und bar bezahlt. Der Meldende berichtet, in den letzten drei Monaten keine Wertpapiere veräußert zu haben, und enthält die übliche Erklärung, dass der Verkäufer keine nicht offengelegten, wesentlichen nachteiligen Informationen besitzt. Die Mitteilung enthält die üblichen Unterschriften- und Rechtsbeglaubigungsformeln.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What does Disc Medicine's (IRON) Form 144 report?

The Form 144 reports a proposed sale of 12,862 common shares with an aggregate market value of $785,868.20, to be sold on 08/14/2025 via Merrill Lynch.

How many Disc Medicine shares are outstanding per the filing?

The filing lists 34,765,581 shares outstanding.

When and how were the shares being sold originally acquired?

The shares were acquired on 05/01/2020 in a private placement from the issuer and the purchase was paid in cash.

Were any Disc Medicine (IRON) securities sold in the past three months?

The filing states Nothing to Report for securities sold during the past three months.

Which broker is handling the proposed sale?

The proposed sale is to be executed through Merrill Lynch One Bryant Park, New York, NY.
Disc Medicine Inc

NASDAQ:IRON

IRON Rankings

IRON Latest News

IRON Latest SEC Filings

IRON Stock Data

2.12B
27.36M
10.65%
99.18%
8.18%
Biotechnology
Pharmaceutical Preparations
Link
United States
WATERTOWN